Ornithine

Drug profile

Key facts

Ornithine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including GPRC6A. Recorded indications include Female Facial Hirsutism.

• Molecular targets: GPRC6A (1 listed in DrugCentral).
• Indications: Female Facial Hirsutism.
• Molecular formula: C5H12N2O2; molecular weight 132.16 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Female Facial Hirsutism

Contraindications (2)

• Eruption of skin
• Skin irritation

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
G-protein coupled receptor family C group 6 member A	GPRC6A	agonist	EC50 4.00

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ornithine is on its molecule page.

• Molecular formula: C₅H₁₂N₂O₂
• Molecular weight: 132.16 g/mol
• CAS number: —
• InChIKey: AHLPHDHHMVZTML-BYPYZUCNSA-N
• PubChem CID: 6262

NCCC[C@H](N)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ornithine used for?

DrugCentral lists the following indications for Ornithine: Female Facial Hirsutism.

How does Ornithine work?

Its molecular targets in DrugCentral include GPRC6A (agonist).

What is the chemical formula of Ornithine?

Ornithine has the molecular formula C5H12N2O2 and a molecular weight of 132.16 g/mol.

Sources

• DrugCentral drug card 3401 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL446143 — compound record and bioactivity
• PubChem CID 6262 — chemical identifiers
• DrugBank DB00129 — drug record
• FDA UNII E524N2IXA3 — substance identity
• UniProt Q5T6X5 (GPRC6A) — target protein

How this page is built: methodology · editorial policy & corrections.